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ABSTRACT 
Trace elements are receiving too much attention as they are found to be significantly altered in head and neck, 
lung and breast carcinomas, and there is need to develop sensitive, specific and faster tests as an aid in the 
early diagnosis of the primary tumor and its recurrence or malignant transformation in premalignant 
states.Aim: To estimate serum copper and zinc levels in Oral Submucous Fibrosisand oral squamous cell 
carcinoma patients. Methodology: Sera of OSCC (n = 10) and OSMF (n = 10) patients and of healthy controls 
was analysed for the estimation of Cu and Zn using atomic absorption spectrophotometry. Results: There was 
an increase in sera levels of Cu while those of Zn were decreased in both Oral Submucous fibrosis and Oral 
Squamous Cell Carcinoma patients as compared to the healthy controls. Conclusion: It could be concluded that 
there is an alteration of sera levels of these trace elements which can be helpful in early detection and 
management in OSMF and OSCC patients. 
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Introduction 
With anincrease in incidence of oral precancerous 
and cancerous lesions in Indian there is a necessity 
of in depth probing of various etiological as well as 
contributory factors for its early diagnosis and 
prognosis.[1]Dueto rapid economic development 
the adoption of a lifestyle with high risk habits 
further adds to the impact of cancer.[2] Among the 
various premalignant conditions of the oral cavity, 
Oral Submucous Fibrosisis of special concern not 
only due to its crippling condition that it produces 
in the patient but as the entire oral mucosa acquires 
malignant potential.[3]At present the confirmation 
of a lesion being precancerous and cancerous is 
done by histopathology. Recently, in the detection 
and diagnosis of oral cancer and precancerous 
lesions trace elements are receiving too much 
attention as they are found to be significantly 
altered in head and neck, lung and breast 
carcinomas. Trace elements have an important role 
in carcinogenesis.[1]Zinc and copper have been 
studied of the trace elements in patients with 
malignant disease and these elements in serum has 
been found to be reliable parameter as a diagnostic 
and prognostic index in case of craniofacial 
tumours.[4] Very few studies have been conducted 
to find out the role of different trace elements in 
oral precancer and cancer. Hence we present a 
comprehensive study to estimate levels of serum 
copper, zinc and Cu/Zn ratio in patients with Oral 
Submucous Fibrosisand Oral Squamous Cell 
Carcinoma in Northern India. 
 
Material and Method 
The study sample comprised thirty participants that 
were divided into four groups as: 
 Group A: Patients with clinical and 
histopathologically diagnosed Oral 
Submucous Fibrosis, n = 10 
 Group B: Patients with clinical and 
histopathologically diagnosed Oral Squamous 
Cell Carcinoma, n = 10 
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 Group C: Healthy controls without any habit 
and without lesion (tobacco, betel nut, and 
alcohol consumption), n = 5 
 Group D: Healthy controls with habit but 
without any lesion (tobacco and/or betel nut 
and/or alcohol consumption), n = 5 
Methodology 
A detailed oral examination of the patients was 
carried out using diagnostic instruments (mouth 
mirror and probe), and findings were recorded. A 
clinical diagnosis of Oral Submucous Fibrosis or 
the malignant ulcer was made based on the clinical 
appearance of the lesion, and a detailed case 
history was taken. Biopsy was taken from the site 
of the lesion. Biopsy tissue was processed and 
stained, and the diagnosis was histopathologically 
confirmed. 2ml of intravenous blood was drawn 
under aseptic precautions. The blood was allowed 
to clot and centrifuged at 1000 rpm for 15 min to 
separate serum. Serum was subjected to digestion 
using concentrated nitric acid and perchloric acid. 
For the determination of serum Cu, the sample was 
diluted with an equal volume of deionized water. 
For the determination of serum Zn, the sample was 
diluted in a ratio of 1:5 with deionized water. 
Estimation of serum Cu and Zn levels was done 
using AAS (Perkin Elmer, Shelton, CT 06484, 
USA Analyst 200/4000 spectrometer). 
 
Stastical analysis 
Data were entered into Microsoft Excel sheet and 
analyzed using Statistical Package for Social 
Sciences (Graph pad prism, Version 6.07) (SPSS 
Inc., Chicago, USA). Analysis of variance 
(ANOVA) was used to compare the results of 
patients of Oral Submucous Fibrosis, Oral 
Squamous Cell Carcinomapatients, and the 
controls. Independent sample's t-test was used to 
compare the mean values between the two groups. 
Comparison of mean values between different 
groups was done using the Student's t-test using 




The mean serum copper levels in OSMF and 
OSCC was significantly increased as compared to 
healthy control with habit or without habit as seen 
in Table I. In [Table II], statistical analysis by 
ANOVA test showed a mean serum Zn level in 
OSMF patients of 80.40 ± 6.610 μg/dl and in 
OSCC patients of 59.63 ± 6.846 μg/dl which were 
significantly lower (P < 0.0001) as compared to the 
healthy controls in Group C, wherein a mean serum 
Zn level of 97.67 ± 4.865 μg/dl and Group D 
wherein a mean of 100.1 ± 4.559 μg/dl were 
found.As per [Table III], statistical analysis using 
ANOVA test showed mean serum Cu/Zn ratio in 
OSMF patients of 1.682 ± 0.1433 μg/dl and in 
OSCC patients of 2.323 ± 0.3225 μg/dl which were 
found to be significantly greater with a P< 0.05 as 
compared to the healthy controls in Group C, 
wherein a mean 1.106 ± 0.0678 μg/dl and group D, 
wherein a mean of 1.057 ± 0.0677 μg/dl were 
found. In [Table IV] the mean serum Cu/Zn levels 
in OSMF and OSCC were significantly increased 
as compared to the control groups.  
 
Discussion 
Oral cancer is ranked as eleventh most common type 
of cancer worldwide with over 130,000 reported 
deaths annually. Most commonly seen in south and 
south East Asian countries such as India, Taiwan, 
Bangladesh and Srilanka.[5]India has one of the 
highest incidence of oral cancer in the world. The 
development of cancer is a multistep process arising 
from pre-existing potentially malignant 
lesion.[2]There is also a high rate of malignant 
transformation of premalignant states like oral 
leukoplakia and Oral Submucous fibrosis. 
In the present study, serum Cu levels were analyzed 
among Oral Submucous Fibrosis, Oral Squamous 
Cell Carcinoma, and the select control groups. Study 
results revealed that increase in mean serum Cu 
levels were observed in Oral Squamous Cell 
Carcinoma and Oral Submucous Fibrosis groups 
when compared to the control groups.  
The results were similar to the study done by 
Haines et al[6] in which Cu levels were higher than 
the control group. KhannaS[7], Jayadeep A et al[8]., 
Haider SM et al[9]. And Shetty SR et al.[10], also 
reported increased Cu levels in the sera of patients 
with oral premalignant and malignant 
lesions.Margalith et al.[11] suggested that role of Cu 
ions in biological damage is due to superoxide 
radicals or other reducing agents such as ascorbate, 
which eventually leads to damage to proteins, 
ribonucleic acid (RNA), and deoxyribonucleic acid 
(DNA), that are not repairable by cellular 
mechanisms, thereby initiating the malignant process. 
Jayadeep A et al[8], in their study, reported that the 
rise in serum Cu levels might be due to increased 
turnover of ceruloplasmin (a Cu carrying globulin 
with essential oxidase activity) in carcinoma 
patients.Following chewing, the uptake of Cu into the 
epithelial cells occurs probably by a nonenergy 
dependent diffusion where it is either bound to the 
proteins (mainly metallothioneins) or transferred 
across the basement membrane.The exact mechanism 
of Cu-induced mutagenesis is not fully understood. 
Cu-induced DNA damage has been reported, and 
there is evidence to suggest that Cu may bind to the 
protein product of p53, the major tumor suppressor 
gene, resulting in alteration of its 
conformation.12Trivedy CR et al.13 have also 
reported Cu-induced mutagenesis through the p53 
aberrations in Oral Submucous Fibrosiswhich might 
be critical in the progression of the potentially 
malignant lesion to Oral Squamous Cell Carcinoma. 
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However, the findings of the present study 
contradict the findings of the study conducted by 
Varghese et al.14who found a significant reduction 
in serum Cu levels in Oral Submucous 
Fibrosispatients. In the present study, the mean 
serum Zn levels were analyzed among three 
groups. The study results revealed that there was 
decrease in mean serum Zn levels among group A 
and group B compared to the control groups (C, 
D). The results were in accordance with the various 
studies conducted by Varghese I et al14 in OL, 
OSF, Oral Squamous Cell Carcinoma, Abdulla 
M et al15 in head and neck cancers, Jha IN et al in 
oral cancers and Toke GB and Dhamne BK in head 
and neck cancers, in the past. Decreased sera levels 
of zinc have, also, been reported in patients 
suffering from gastrointestinal cancers, 
gynecological tumors, lymphomas, and breast and 
lung carcinomas. Altered sera zinc levels have, 
also, been correlated with decreased appetite in 
patients with advanced malignancies, especially, 
oral cancers.  
Similar findings were found in the study 
conducted by VashisthaA et al16 on patients with 
oral cancer (oral squamous cell carcinoma) and 
oral sub-mucous fibrosis (Oral Submucous 
Fibrosis) associated with habit of tobacco 
consumption in any form as compared to the 
healthy controls.  
Shetty SR et al,10 also, found decrease in sera 
levels of zinc in patients with oral pre-cancers and 
cancers as compared to the controls. Kapil U et 
al, 17 observed that 53% of oral cancer patients in 
Jharkand had serum zinc deficiency and the 
deficiency was higher in females as compared to 
the males. 
This could be because the malignant cells 
probably require more zinc which is taken up 
from the serum causing low levels of zinc in it. 
As there is negative interaction between copper 
and zinc, an increase in copper level may cause 
subsequent reduction in zinc level as well.[18] 
In the present study, mean serum Cu/Zn ratio was 
analyzed amongst the three groups and the study 
results revealed that there was a significant (p < 
0.0001) increase in mean serum Cu/Zn ratio in 
groups A and B when compared to the controls 
(Groups C, D).  
Similar findings were observed in earlier studies 
done by Jayadeep A et al,[8]Shetty SR et al[10], 
Varghese I et al,[14] Abdulla M et al,[15]Jha 
IN et al,[19] Toke GB [20] and  Altered copper 
zinc ratio has, also, been observed in patients 
suffering from pancreatic cancers, gastric cancers, 
lymphomas, malignant lung tumors and breast 
cancers.  
Thus, from the present study, it can be inferred 
that serum copper and Cu/Zn ratio was 
significantly higher in Oral Submucous Fibrosis 
and Oral Squamous Cell Carcinoma patients 
while simultaneously, there was a significant 
reduction in mean serum zinc levels when 
compared with the controls.  
Thus, the alteration in serum copper and zinc and 
Cu/Zn ratio can be used as a potential biomarker 
in early detection of numerous oral pre-cancerous 
lesions and conditions and cancers as well as their 
malignant transformation and turning into frank 
cancers at an early enough stage. 
 
Table I: Comparison of Serum copper level 
 





Group A (OSMF) 10 127 140 134.8 + 4.197 
Group B (OSCC) 10 126 144 136.8 + 5.499 
Group C (with habit  
& without lesion) 
5 98 115 108.3 + 5.080 
Group D (Without 
habit, without lesion) 
5 96 112 106.1 +5.257 
 
Table II: Comparison of Serum copper level 
 




Mean + SD 
Group A (OSMF) 10 72 90 80.40 + 6.610 
Group B (OSCC) 10 49 73 59.63 + 6.846 
Group C (with habit  & 
without lesion) 
5 90 104 97.67 + 4.865 
Group D (Without 
habit, without lesion) 
5 92 107 100.1 + 4.559 
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Table III: Comparison of mean copper/Zinc ratio 
 




Mean + SD 
Group A (OSMF) 10 1.47 2.05 1.682 + 0.1433 
Group B (OSCC) 10 1.78 2.93 2.323 + 0.3225 
Group C (with habit  & 
without lesion) 
5 1.02 1.24 1.106 + 0.0678 
Group D (Without 
habit, without lesion) 
5 0.93 1.17 1.057 + 0.0677 
 
Table IV: Comparison of Mean Serum Copper, Zinc and mean copper/Zinc ratio 
 






Group A (OSMF) 134.8 + 4.197 80.40 + 6.610 1.682+ 0.1433 
Group B (OSCC) 136.8 +5.499 59.63 + 6.846 2.323 + 0.3225 
Group C (with habit  & 
without lesion) 
108.3 + 5.080 97.67 + 4.865 1.106 + 0.0678 
Group D (Without habit, 
without lesion) 




 Determination of sera levels of Cu and Zn is 
simple as well as an inexpensive procedure 
and can be used as an adjunct screening tool 
for determining risk in patients with 
potentially malignant Oral Submucous 
Fibrosis and/or frank Oral Squamous Cell 
Carcinoma.  
 The significant alteration in the levels of Cu 
and Zn in sera may be due to the cellular 
metabolic changes that occur during the 
pathogenesis of Oral Submucous Fibrosis and 
Oral Squamous Cell Carcinoma. Thus, more 
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